Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Alexar Therapeutics
101 Lindenwood Dr. Ste. 400
Malvern, PA 19355
Phone: 484-318-2988
www.alexartx.com

Alexar Therapeutics, Inc. is focused on developing an innovative portfolio of Liver X receptor (LXR) agonists.

Key Contact
Name
Dave Pfeiffer
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/02/14 $21,500,000 Series A New Science Ventures
NeXeption
Palo Alto Investors
Third Point Ventures
undisclosed


Featured Reading